Biolase, Inc.
BIOL
BIOL was delisted on the 18th of June, 2024.
36 hedge funds and large institutions have $53.8M invested in Biolase, Inc. in 2015 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 5 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
0% more funds holding
Funds holding: 36 → 36 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
17% less capital invested
Capital invested by funds: $64.6M → $53.8M (-$10.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$4.16M |
| 2 |
VAM
Visium Asset Management
New York
|
+$3.4M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$850K |
| 4 |
RA
Royce & Associates
New York
|
+$368K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$255K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$849K |
| 2 |
ACA
Avoro Capital Advisors
New York
|
-$227K |
| 3 |
MCM
Murphy Capital Management
Bedminster,
New Jersey
|
-$125K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$85K |
| 5 |
Millennium Management
New York
|
-$80K |
BIOL Hedge Fund Activity: Q1 2015 in Review
36 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q1 2015, worth a combined $53.8M — down 17% from $64.6M a quarter earlier.
Fund positioning in BIOL was balanced in Q1 2015: 5 funds opened new positions, 5 closed out, 8 added to existing stakes and 7 trimmed.
The largest buyer was Camber Capital Management, adding an estimated $4.16M. The largest seller was Perkins Capital Management, exiting entirely with an estimated $849K sold.
- 36 institutional investors held Biolase, Inc. (BIOL) as of Q1 2015, unchanged from Q4 2014.
- Funds reported $53.8M of Biolase, Inc. stock for Q1 2015, down 17% quarter-over-quarter.
- 5 funds opened new Biolase, Inc. positions in Q1 2015 and 5 closed out, a net change of 0 holders.
- The largest Biolase, Inc. buyer in Q1 2015 was Camber Capital Management, an estimated $4.16M added.
- The largest Biolase, Inc. seller in Q1 2015 was Perkins Capital Management, an estimated $849K sold.
Based on aggregated 13F filings for Q1 2015.